Copyright
©The Author(s) 2015.
World J Diabetes. Nov 25, 2015; 6(16): 1312-1322
Published online Nov 25, 2015. doi: 10.4239/wjd.v6.i16.1312
Published online Nov 25, 2015. doi: 10.4239/wjd.v6.i16.1312
Table 1 Care parameters for basic treatment of uncomplicated diabetes and for the treatment of chronic and acute complications
Medical conditions | Care component | Guidelines |
Uncomplicated diabetes | ||
Consultation of diabetes specialist or a general practitioner | 4/yr | |
Fasting glucose test | 4/yr | |
Urine glucose test | 6/yr | |
Glycated hemoglobin | 2/yr | |
Proteinuria test | 1/yr | |
Blood lipid test TG, HDL-cholesterol, LDL-cholesterol | 1/yr | |
Electrocardiogram | 1/yr | |
Chest X-ray | 1/yr | |
Ophthalmology consult | 1/yr | |
Oral hypoglycemic agents | ||
Glibenclamide 5 mg OR in combination with metformin | 3 tablets/d | |
Metformin® 500 mg | 3 tablets/d | |
Glucophage® 850 mg OR in combination with Amarel® | 3 tablets/d | |
Amarel® 4 mg | 1 tablet/d | |
For insulin users | ||
Syringes | 1/wk (min)-1/d (max) | |
Insulin | 30 UI (min) et 60 UI (max)/d | |
Strips for blood glucose control | 1 strip/d (min) | |
3 strips/d (max) | ||
Glucometer | 1 (Duration: 2 yr) | |
Chronic complications | ||
Proliferative retinopathy | ||
Consultation in ophthalmology | 3/yr | |
Retinography | 1/yr | |
Laser photocoagulation | 1/yr | |
Overt nephropathy | ||
Consultation in nephrology | 2/yr | |
Blood creatinine test | 2/yr | |
Serum protein test | 2/yr | |
Serum electrolytes test (sodium, potassium) | 2/yr | |
Urinary electrolytes test (sodium, potassium) | 2/yr | |
Urine creatinine test | 2/yr | |
Proteinuria | 2/yr | |
Hemogram | 2/yr | |
Urine bacteriology | 4/yr | |
Urine culture (ECBU) | 1/yr | |
Antiplatelet drugs | ||
Aspirin® 100 mg OR | 1 tablet/d | |
Plavix® 75 mg | 1 tablet/d | |
Antihypertensive (ARA2) | ||
Valsartan® 80 mg | 1 tablet/d | |
Diuretics: | ||
Laxilix® 40 mg OR | 3 tablets/d | |
Laxilix® special 500 mg | Half tablet/d | |
Calcium carbonate (added to antiplatelet therapy, maximum cost) | 2 tablets/d | |
Statin (added to antiplatelet therapy, maximum cost) | 1 tablet/d | |
Renal failure | ||
Dialysis | 2 session/wk | |
Potex® 4000 UI (EPO) | 50 UI/kg weight (max) | |
2 sessions/wk | ||
Calcium carbonate 500 mg | 1.5 g or 3 tablets/d (max) | |
Ischemic heart disease | ||
Consultation in cardiology | 2/an | |
Antiplatelet drugs | See under nephropathy | |
Statins | ||
Simvastatin (Zocor®) OR | 1 tablet/d | |
Atorvastatin (Tahor®) | 1 tablet/d | |
Exercise electrocardiogram testing | 1/yr | |
Echo doppler | 1/yr | |
Cardiac ultrasound | 1/yr | |
Coronarography | 1/yr | |
Hypertension | ||
Consultation in cardiology | 1/yr | |
Antihypertensive drugs (ACEI) | ||
Captopril® 25 mg OU | 3 tablets/d | |
Ramipril® 5 mg | 1 tablet/d | |
Diuretics | See under nephropathy | |
Aggregation inhibitors | See under nephropathy | |
Semi quantitative urine protein test | 2/yr | |
Blood creatinine test | 2/yr | |
Proteinemia | 2/yr | |
Blood electrolytes test (Na, K, Ca) | 2/an | |
Stroke (chronic phase) | ||
Consultation in cardiology | 2/yr | |
Antiplatelet drugs | See under nephropathy | |
Diabetic foot | ||
Consultation in podiatry | 1/yr | |
Arteriography of the lower limbs | 1/yr | |
Physiotherapy sessions | 10-20 sessions/yr | |
Echo doppler | 1/yr | |
Statins | See under ischemic heart disease | |
Antiplatelet drugs | 1 tablet/d | |
Orthopedic shoes | 2 pairs/yr | |
Acute complications | ||
Ketoacidosis | ||
Hospitalization | 7 d | |
Blood glucose test | Done once during hospitalization | |
Glycated hemoglobin | Done once during hospitalization | |
Hemogram | Done once during hospitalization | |
Blood lipids test | Done once during hospitalization | |
Blood electrolytes test (Na, K) | Done once during hospitalization | |
Blood creatinine test | Done once during hospitalization | |
Blood urea test | Done once during hospitalization | |
Electrocardiogram | Done once during hospitalization | |
Chest X- ray | Done once during hospitalization | |
Echo doppler | Done once during hospitalization | |
Keto-Diastix® box of 50 strips (blood biology) | 3 times/d for 3 d | |
Perfusion | 3 d | |
Diabetic foot (acute) | ||
Hospitalization | 90 d | |
Antibiotics | ||
Oxaciline® 500 mg | 4 tablets/d | |
3 wk of treatment without bone involvement (min); 10 wk when bone involved (max) | ||
Vasodilator: Vastarel® 35 mg | 2 tablets/d, 22 wk | |
Biopsy | Done once during hospitalization | |
Antibiogram | Done once during hospitalization | |
Bone radiography | Done once during hospitalization | |
Vascular ultrasound | Done once during hospitalization | |
Dressings | 1/wk, 22 wk | |
Foot surgery | ||
Minor surgery (56%) | ||
Major surgery, amputation (44%) | ||
Prosthesis | ||
End stage renal disease | ||
Hospitalization | 30 d | |
Ultrasound | Done once during hospitalization | |
Electrolytes blood test (Na, K) | Done once during hospitalization | |
Creatinine blood test | Done once during hospitalization | |
Proteinemia | Done once during hospitalization | |
Stroke | ||
Hospitalization | 18 d | |
Vasodilatator: Vastarel® 35 mg | 2 tablets/d, 18 d | |
Anticoagulants | 1 tablet/d, 18 d | |
Rehabilitation/physical therapy | 18 d |
- Citation: Alouki K, Delisle H, Besançon S, Baldé N, Sidibé-Traoré A, Drabo J, Djrolo F, Mbanya JC, Halimi S. Simple calculator to estimate the medical cost of diabetes in sub-Saharan Africa. World J Diabetes 2015; 6(16): 1312-1322
- URL: https://www.wjgnet.com/1948-9358/full/v6/i16/1312.htm
- DOI: https://dx.doi.org/10.4239/wjd.v6.i16.1312